Literature DB >> 17828603

Reproducibility and reliability of tumor grading in urological neoplasms.

Rainer Engers1.   

Abstract

Histopathologic tumor grading reflects the degree of differentiation of a given tumor and for most urological tumors grading is an important factor in predicting their biological aggressiveness. Consequently, the clinical management of tumor patients is often strongly influenced by the tumor grade, provided by pathologists. This implicates that an ideal grading system should not only be of high prognostic relevance, but also of high reproducibility among different pathologists. To this end individual histological grading systems have been developed for different tumor entities and even for a given tumor type several grading systems have been proposed. All of these grading systems possess an inherent degree of subjectivity and consequently, both intra- and interobserver variability exist. In this review, grading systems for the most frequent urological tumors (i.e. prostate cancer, renal cell carcinoma, and urothelial tumors) are mentioned and data on the reproducibility and reliability of the most commonly used grading systems are summarized.

Entities:  

Mesh:

Year:  2007        PMID: 17828603     DOI: 10.1007/s00345-007-0209-0

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  78 in total

1.  Current practice of Gleason grading among genitourinary pathologists.

Authors:  Lars Egevad; William C Allsbrook; Jonathan I Epstein
Journal:  Hum Pathol       Date:  2005-01       Impact factor: 3.466

Review 2.  Current practice of Gleason grading of prostate carcinoma.

Authors:  Antonio Lopez-Beltran; Gregor Mikuz; Rafael J Luque; Roberta Mazzucchelli; Rodolfo Montironi
Journal:  Virchows Arch       Date:  2005-11-23       Impact factor: 4.064

3.  The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.

Authors:  Burkhard Helpap; Lars Egevad
Journal:  Virchows Arch       Date:  2006-11-08       Impact factor: 4.064

4.  A web-based tutorial improves practicing pathologists' Gleason grading of images of prostate carcinoma specimens obtained by needle biopsy: validation of a new medical education paradigm.

Authors:  J D Kronz; M A Silberman; W C Allsbrook; J I Epstein
Journal:  Cancer       Date:  2000-10-15       Impact factor: 6.860

5.  Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.

Authors:  Vincenzo Ficarra; Guido Martignoni; Nicola Maffei; Matteo Brunelli; Giacomo Novara; Luisa Zanolla; Maurizio Pea; Walter Artibani
Journal:  Cancer       Date:  2005-01-01       Impact factor: 6.860

6.  Histologic grading of prostatic adenocarcinoma: intraobserver reproducibility of the Mostofi, Gleason and Böcking grading systems.

Authors:  M L Cintra; A Billis
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

7.  Combined histologic grading of prostatic carcinoma.

Authors:  A Böcking; J Kiehn; M Heinzel-Wach
Journal:  Cancer       Date:  1982-07-15       Impact factor: 6.860

8.  The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.

Authors:  Jonathan L Curry; Eva M Wojcik
Journal:  Cancer       Date:  2002-06-25       Impact factor: 6.860

9.  Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder.

Authors:  Kutsal Yorukoglu; Burcin Tuna; Emel Dikicioglu; Ender Duzcan; Aydin Isisag; Sait Sen; Ugur Mungan; Ziya Kirkali
Journal:  Virchows Arch       Date:  2003-10-08       Impact factor: 4.064

10.  Evaluation of the interobserver reproducibility of Gleason grading of prostatic adenocarcinoma using tissue microarrays.

Authors:  Alexandre De la Taille; Annick Viellefond; Nicole Berger; Eric Boucher; Marc De Fromont; Alain Fondimare; Vincent Molinié; Dominique Piron; Mathilde Sibony; Frédéric Staroz; Marie Triller; Eric Peltier; Nicolas Thiounn; Mark A Rubin
Journal:  Hum Pathol       Date:  2003-05       Impact factor: 3.466

View more
  18 in total

1.  Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreement.

Authors:  Michelle D Reid; Adeboye O Osunkoya; Momin T Siddiqui; Stephen W Looney
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

Review 2.  Current Concepts in the Management of Non-Muscle Invasive Bladder Cancer.

Authors:  Anil Mandhani
Journal:  Indian J Surg Oncol       Date:  2017-06-06

3.  Digital pathology image analysis: opportunities and challenges.

Authors:  Anant Madabhushi
Journal:  Imaging Med       Date:  2009

Review 4.  All change in the prostate cancer diagnostic pathway.

Authors:  Derek J Lomas; Hashim U Ahmed
Journal:  Nat Rev Clin Oncol       Date:  2020-02-28       Impact factor: 66.675

5.  Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsies.

Authors:  Meredith V Brown; Jonathan E McDunn; Philip R Gunst; Elizabeth M Smith; Michael V Milburn; Dean A Troyer; Kay A Lawton
Journal:  Genome Med       Date:  2012-04-30       Impact factor: 11.117

6.  Reproducibility and prognostic value of WHO1973 and WHO2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder.

Authors:  Ok Målfrid Mangrud; Rune Waalen; Einar Gudlaugsson; Ingvild Dalen; Ilker Tasdemir; Emiel A M Janssen; Jan P A Baak
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

7.  Changes in cell shape are correlated with metastatic potential in murine and human osteosarcomas.

Authors:  Samanthe M Lyons; Elaheh Alizadeh; Joshua Mannheimer; Katherine Schuamberg; Jordan Castle; Bryce Schroder; Philip Turk; Douglas Thamm; Ashok Prasad
Journal:  Biol Open       Date:  2016-02-12       Impact factor: 2.422

8.  New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression.

Authors:  Raymond A Clarke; Zhongming Zhao; An-Yuan Guo; Kathrein Roper; Linda Teng; Zhi-Ming Fang; Hema Samaratunga; Martin F Lavin; Robert A Gardiner
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

9.  Markers for detection of prostate cancer.

Authors:  Raymond A Clarke; Horst J Schirra; James W Catto; Martin F Lavin; Robert A Gardiner
Journal:  Cancers (Basel)       Date:  2010-06-04       Impact factor: 6.639

10.  Reinventing diagnostics for personalized therapy in oncology.

Authors:  Diponkar Banerjee
Journal:  Cancers (Basel)       Date:  2010-06-02       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.